US FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
US FDA
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
Apr 28, 2024, 13:23 |
Drugs
Sam Blackman: US FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma
Sam Blackman, Co-founder and Chief Medical Officer of Day One Biopharmaceuticals, shared a post by Day…
Apr 24, 2024, 22:44 |
Blog
Amol Akhade: Can u pronounce name of this latest approved drug by US FDA correctly?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared a post on X: "Can u…
Apr 20, 2024, 07:47 |
Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Mar 28, 2024, 03:11 |
Drugs
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Feb 14, 2024, 06:32 |
Insight
Amol Akhade: What is the approach of Indian Oncologist Towards Drug approval agencies?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared on X/Twitter: "What is the…
Dec 9, 2023, 16:52 |
Opinion
Lisa A. Lacasse: We are disappointed after hearing this announcement
Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post on LinkedIn:…
Oct 5, 2023, 17:41 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the ESMO MAP23 meeting in Paris, France this week, Oct 4-6.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
All:
9
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube